SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

NIKE, Inc. engages in the design, development, marketing, and sale of athletic footwear, apparel, accessories, equipment, and services. It operates through the following segments: North America, Europe, Middle East, and Africa (EMEA), Greater China, Asia Pacific and Latin America (APLA), Global Brand Divisions, Converse, and Corporate. The North America, EMEA, Greater China, and APLA segments refer to the design, development, marketing, and selling of athletic footwear, apparel, and equipment. The Global Brand Divisions segment represents its NIKE Brand licensing businesses. The Converse segment designs, markets, licenses, and sells casual sneakers, apparel, and accessories. The Corporate segment is composed of unallocated general and administrative expenses. The company was founded by William Jay Bowerman and Philip Hampson Knight on January 25, 1964 and is headquartered in Beaverton, OR.

Nike, Inc. - Ordinary Shares - Class B

Nike Inc

Nike is trending after reporting an earnings beat that was overshadowed by significant concerns over declining sales in Greater China, pressured gross margins due to tariffs, and a cautious outlook. The community is intensely debating whether the sharp stock decline is an overreaction and a long-term buying opportunity, or if it signals deeper issues for the brand amid stiff competition and shifting consumer sentiment, particularly regarding its China strategy and perceived lack of innovation.

Carnival Corp. engages in the operation of cruise ships. It operates through the following business segments: North America and Australia (NAA) Cruise, Europe and Asia (EA) Cruise Operations, Cruise Support, and Tour and Others. The North America and Australia (NAA) Cruise segment includes the Carnival Cruise Line, Holland America Line, Princess Cruises, and Seabourn. The Europe and Asia (EA) Cruise Operations segment consists of AIDA, Costa, Cunard, and P&O Cruises (UK). The Cruise Support segment represents port destinations and private islands for the benefit of its cruise brands. The Tour and Other segment operates hotel and transportation operations of Holland America Princess Alaska Tours. The company was founded in 1972 and is headquartered in Miami, FL.

Carnival Corp. - Ordinary Shares (Paired Stock)

Carnival Corp

Carnival (CCL) is actively discussed ahead of its earnings, with the community split between expectations of a significant rally driven by robust bookings and strong cruise demand, and worries about potential market manipulation. Many investors see the stock as fundamentally undervalued, pointing to improving financials and favorable macroeconomic factors like falling oil prices and interest rates. However, skepticism lingers about the stock's ability to consistently break higher despite these positive indicators.

Intuitive Machines, Inc. is a space exploration, infrastructure, and services company, which engages in contributing to the establishment of cislunar infrastructure and helping to develop cislunar and deep space commerce. It offers space products and services. The company was founded by Stephen J. Altemus, Kam Ghaffarian, and Timothy P. Crain in 2013 and is headquartered in Houston, TX.

Intuitive Machines Inc - Ordinary Shares - Class A

Intuitive Machines Inc

Intuitive Machines (LUNR) is trending with high anticipation for an imminent NASA Lunar Terrain Vehicle (LTV) contract award, a potential catalyst that the community believes could ignite significant movement. This excitement is fueled by recent analyst upgrades, a broader executive order emphasizing American space superiority, and widespread discussion of a potential short squeeze due to substantial short interest.

DraftKings, Inc. is a digital sports entertainment and gaming company, which engages in the provision of online sports betting, online casino, daily fantasy sports product offerings, DraftKings Marketplace, retail sportsbook, media, and other consumer product offerings. The company was founded by Jason D. Robins, Matthew Kalish, and Paul Liberman on December 31, 2011 and is headquartered in Boston, MA.

DraftKings Inc. - Ordinary Shares - Class A

DraftKings Inc

DraftKings is trending due to the highly anticipated launch of its new 'Predictions' app, signaling a strategic expansion into event-based betting. The community is actively discussing its potential market impact and how recent regulatory crackdowns on competitor prediction platforms might benefit DraftKings' federally regulated approach.

Rivian Automotive, Inc. engages in the design, development, and manufacture of category-defining electric vehicles and accessories. It operates through following segments: Automotive, Software and Services. The company was founded by Robert J. Scaringe in June 2009 and is headquartered in Irvine, CA.

Rivian Automotive Inc - Ordinary Shares - Class A

Rivian Automotive Inc

Rivian is experiencing substantial market attention driven by recent analyst upgrades and a renewed focus on its self-driving technology advancements. The community is buzzing about the rollout of its "Universal Hands-Free" driving feature and the strategic integration of in-house AI chips, shifting the narrative beyond just EV manufacturing. This renewed optimism, fueled by the company's autonomy roadmap and anticipation for its R2 vehicle, has sparked widespread bullish discussions, with many comparing its growth potential to established EV leaders.

Amicus Therapeutics, Inc. is a biotechnology company, which focuses on discovering, developing, and delivering medicines for people living with metabolic diseases. Its product portfolio includes first and only approved oral precision medicine for people living with Fabry disease who have amenable genetic variants, a novel, clinical-stage, treatment paradigm for Pompe disease and a rare disease gene therapy portfolio. The company was founded by John Francis Crowley on February 4, 2002 and is headquartered in Princeton, NJ.

Amicus Therapeutics Inc

Amicus Therapeutics ($FOLD) is the subject of widespread discussion following BioMarin Pharmaceutical's announced acquisition for approximately $4.8 billion in cash. The community is reacting strongly, with many celebrating the substantial premium while others voice disappointment, believing the company was acquired for an undervalue. This significant rare disease biotech buyout highlights ongoing M&A trends within the sector.

WhiteFiber, Inc. provides AI and HPC infrastructure & cloud and data center solutions. It operates through the following segments: Cloud Services and Colocation Services. The Cloud Services segment offers computing services to support generative AI workstreams. The Colocation Services segment provides customers with physical space, power and cooling within the data center facility. The company was founded on August 15, 2024 and is headquartered in New York, NY.

Whitefiber Inc.

WhiteFiber, Inc.

WhiteFiber is trending due to its announced $865 million, 10-year AI data center colocation agreement with Nscale for its NC-1 campus. The community is buzzing with speculation about a potential short squeeze and significant re-rating, given the robust demand in the AI infrastructure sector and the size of the deal. However, some investors express caution, referencing past price volatility and previous communication regarding deal timelines.

FedEx Corp. is a holding company, which engages in the provision of transportation, e-commerce, business services, and business solutions. It operates through the following segments: FedEx Express, FedEx Freight, Corporate, Other, and Eliminations. The FedEx Express segment offers transportation and delivery services. The FedEx Freight segment refers to freight transportation services to business and residences. The FedEx Services segment includes sales, marketing, information technology, communications, customer service, technical support, billing and collection services, and certain back-office functions that support the company's operating segments. The Corporate, Other, and Eliminations segment is involved in the corporate headquarters costs for executive officers and certain legal and finance functions, as well as certain other costs and credits not attributed to the firm's core business. The company was founded by Frederick Wallace Smith on June 18, 1971, and is headquartered in Memphis, TN.

Fedex Corp

FedEx is trending after a robust Q2 earnings beat and a raised fiscal 2026 outlook, fueled by successful cost-cutting initiatives and improved package volumes. Community sentiment is mixed, with bulls celebrating the strong results and analyst upgrades, while skeptics point to ongoing concerns regarding freight operations, global trade headwinds, and the potential for a "sell the news" reaction. As a key transport bellwether, its performance is closely watched for insights into broader logistics sector health.

Lyft, Inc. engages in the provision and management of an online social rideshare community platform. It offers access to a network of shared bikes and scooters for shorter rides and first mile and last-mile legs of multimodal trips, information about nearby public transit routes, and Lyft Rentals to offer riders a view of transportation options when planning any trip. The company was founded by Marcus Cohn, John Zimmer, Rajat Suri, Matt van Horn, and Logan Green in 2007 and is headquartered in San Francisco, CA.

Lyft Inc - Ordinary Shares Cls A

Lyft Inc

Lyft is a trending topic, with a recent Wedbush downgrade sparking debate on its valuation and future in the evolving mobility sector. While some community members voice concerns over driver compensation and intensified competition, many investors are seizing the opportunity to buy, buoyed by the CEO's share purchases, consistent growth in bookings and riders, and ongoing speculation about strategic partnerships or acquisitions in the autonomous vehicle space.

BioMarin Pharmaceutical, Inc. engages in the development and commercialization of therapies for people with serious and life-threatening rare diseases and medical conditions. Its pipeline products include Valoctocogene roxaparvovec, Vosoritide, and BMN 307. The company was founded by John C. Klock, Christopher M. Starr and Grant W. Denison on March 21, 1997, and is headquartered in San Rafael, CA.

Biomarin Pharmaceutical Inc. - Registered Shares

BioMarin Pharmaceutical is actively trending due to its recent multi-billion dollar acquisition of Amicus Therapeutics, which significantly expands its rare disease portfolio with key treatments like Galafold and Pombiliti. The community is discussing how this strategic move makes BioMarin's ambitious revenue targets more tangible, aiming to accelerate growth and strengthen its financial outlook.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Amiral Gestion Invests $3.21 Million in Pacific Biosciences of California, Inc. $PACB

Amiral Gestion purchased a new position in shares of Pacific Biosciences of California, Inc. (NASDAQ:PACB - Free Report) during the second quarter, according to the company in its most recent Form...

Pacific Biosciences of California (NASDAQ:PACB) Trading Down 5.3% - Here's Why

Pacific Biosciences of California (NASDAQ:PACB) Shares Down 5.3% - Should You Sell...

Pacific Biosciences of California (NASDAQ:PACB) Stock Price Down 5.3% - Here's What Happened

Pacific Biosciences of California (NASDAQ:PACB) Stock Price Down 5.3% - Should You Sell...

Pacific Biosciences of California (NASDAQ:PACB) Trading Down 5.8% - Should You Sell?

Pacific Biosciences of California (NASDAQ:PACB) Shares Down 5.8% - What's Next...

Geode Capital Management LLC Increases Position in Pacific Biosciences of California, Inc. $PACB

Geode Capital Management LLC increased its stake in shares of Pacific Biosciences of California, Inc. (NASDAQ:PACB - Free Report) by 6.4% during the second quarter, according to the company in its...

XTX Topco Ltd Has $1.18 Million Stock Holdings in Pacific Biosciences of California, Inc. $PACB

XTX Topco Ltd raised its stake in Pacific Biosciences of California, Inc. (NASDAQ:PACB - Free Report) by 95.5% in the 2nd quarter, according to the company in its most recent disclosure with the...

Pacific Biosciences of California (NASDAQ:PACB) Shares Down 8.2% - Here's What Happened

Pacific Biosciences of California (NASDAQ:PACB) Shares Down 8.2% - Time to Sell...

Is Artivion (AORT) Stock Outpacing Its Medical Peers This Year?

Here is how Artivion (AORT) and Pacific Biosciences of California (PACB) have performed compared to their sector so far this year.

Pacific Biosciences of California, Inc. $PACB Shares Sold by Edmond DE Rothschild Holding S.A.

Edmond DE Rothschild Holding S.A. decreased its position in shares of Pacific Biosciences of California, Inc. (NASDAQ:PACB - Free Report) by 38.8% during the 2nd quarter, according to the company in...

Pacific Biosciences of California (NASDAQ:PACB) Hits New 52-Week High - What's Next?

Pacific Biosciences of California (NASDAQ:PACB) Sets New 1-Year High - Here's Why...

Pacific Biosciences of California, Inc. engages in the development, manufacture, and marketing of advanced sequencing solutions for genetic analysis. It operates through the following geographical segments: America, Europe, Middle East, and Africa, and Asia Pacific. The company was founded by Stephen Turner and Joseph Vincent Bonventre on July 14, 2000 and is headquartered in Menlo Park, CA.

Pacific Biosciences of California Inc

Up more than 2%

Up 0–2%

Flat to down 2%

Down more than 2%

The S&P 500 is modestly lower so far in December, putting the Santa Claus rally in question. The Santa Claus rally refers to the market’s tendency to rise in the final weeks of the year—what do you expect from December 16 through December 31?

What do you expect the S&amp;P 500’s total return to be in the second half of December?

Stocktwits

What do you expect the S&P 500’s total return to be in the second half of December?

Fiscal Period	Estimated	Reported	Surprise	Result
Q4 '25	-$0.15	--	--	N/A
Q3 '25	-$0.15	-$0.13	14.01%	BEAT
Q2 '25	-$0.17	-$0.14	18.13%	BEAT
Q1 '25	-$0.19	-$1.44	-649.71%	MISSED
Q4 '24	-$0.19	$0.01	105.26%	BEAT

PACB
Pacific Biosciences of California Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q4 '25

Historical Earnings

Latest PACB News

PACBPacific Biosciences of California Inc